Persistent poverty, glycemic control and adverse COVID-19 outcomes: a retrospective study using real-world data
Shiori Tanaka1, Shanquela Williams2, Li Zhang3
1Department of Medicine, Division of Internal General Medicine and Population Science, University of Alabama at Birmingham, 701 19th Street South, Birmingham, AL, 35294, USA.
Background:
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the profound impact of diabetes and neighborhood environments on health outcomes. Persistent poverty areas, characterized by long-standing economic deprivation, may contribute to increased risk for severe COVID-19 outcomes, particularly among individuals with poor glycemic control. This study investigated the associations between persistent poverty, longitudinal glycemic control by diabetes status, and adverse COVID-19 outcomes using real world data.
Methods:
We conducted a retrospective analysis using electronic health record (EHR) data from a large Academic health system. The sample included 3,681 adults diagnosed with COVID-19 between March 2020 and January 2021, with available HbA1c and neighborhood level data. Residence in census-tract level persistent poverty areas was categorized as yes vs. no while diabetes status and glycemic control were categorized into five groups based on history of diagnosis and HbA1c measured up to three years prior to infection. Bayesian multivariable logistic regression models assessed independent and multiplicative associations between living in a persistent poverty census tract, glycemic control by diabetes status, and adverse COVID-19 outcomes [e.g. hospitalization, intensive care unit (ICU) admission, and death during hospitalization], controlling for demographics and other social risk factors.
Results:
Among 3,681 patients (mean age 54 years; 60% female; 47% Black), 41.4% were hospitalized, 19.2% were admitted to the ICU, and 6.2% died. Overall, 18.0% resided in persistent poverty areas, 36.2% had diabetes [16.6% undiagnosed diabetes, and 11.1% poorly controlled T2DM]. Residing in persistent poverty areas was associated with an increased risk of hospitalization (OR 1.28, 95% CI: 1.02-1.61), ICU admission (OR 1.40, 95% CI: 1.08-1.80), and mortality (OR 1.50, 95% CI: 1.01-2.22). Patients with undiagnosed diabetes had an increased risk of hospitalization (OR 3.05, 95% CI 2.41-3.86) and mortality (OR 1.96, 95% CI: 1.30-2.97).
Conclusion:
This study highlights that residing in a persistent poverty census tract as well as poor glycemic control independently contribute to COVID-19 outcomes. Ongoing management of glycemic control and early preventive strategies in persistent poverty areas may mitigate adverse outcomes in COVID-19 infection and subsequent sequalae like Long COVID.
More Related Videos
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...


